Conception
Advancing the Future of Fertility
About
Conception develops stem cell technology to create functional egg cells in the laboratory for reproductive purposes. The company uses induced pluripotent stem cells derived from blood, guiding them through developmental stages via stem cell biology, tissue engineering, and computation. Conception is developing in-vitro gametogenesis as a medical therapy with integrated ethical safeguards and a regulatory-aligned approach.
Product
- Value proposition
- Developing stem cell-derived reproductive cells and IVG tech to expand reproductive possibilities and enable safer, reliable in-vitro gametogenesis
- Regulatory
- Exploration of IVG as a medical therapy within existing regulatory frameworks; future clinical use would require formal approval
Founders
- Lauren Berson Sugarman — Founder and CEO
Products
Key features
Technologies
Investors
News
- Founders Everywhere: Lauren Berson Sugarman · 2025-02-12T13:46:08.000Z
- Conceivable Life Sciences Secures $50 Million Series A · 2025-09-15T09:00:00.000Z
- Episode 13: Digital Fertility Revolution - AI, Community & Fertility Support | Conceive’s Lauren Berson - The Turek Clinic · 2026-03-23T18:27:27.000Z
- IVF Automation: The Most Human Story About Robots and AI — Conceivable Life Sciences · 2026-02-04T14:56:57.000Z
- Medium · 2026-02-24T14:06:01.000Z
- After A 6-Figure Fertility Journey, This Founder Built An IVF Startup With ‘Outcome Protection’ · 2026-05-20T12:00:29.000Z
Browse similar startups
Related startups
- Continuia — San Diego, CA
- Coredio — Santa Clara, CA
- DANE HEALTH, INC — Huntington Beach, CA
- Dentscape — San Francisco, CA
- Discovery Genomics, Inc. — irvine, CA
- Diya Health — San Jose, CA
- Conduit Dental — Knoxville, TN
- Connect4Patients — Flower Mound, TX
- Continua Systems — Seattle, WA
- Conult Health Analytics — Pittsburgh, PA
- CONWAY HEMATOLOGY ONCOLOGY PLLC — Conway, AR
- CoordiNation Centric — Bryan, TX
Profile updated Jul 29, 2026. Sources: conception.bio


